디지털 치료제(DTx) 시장 : 용도별, 제품 유형별, 판매 채널 및 B2C별, 지역별
Digital Therapeutics Market, By Application, By Product Type (Software and Device), By Sales Channel and Business-to-Consumer (B2C) (Patient and Caregiver), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
상품코드
:
1741140
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
디지털 치료제(DTx) 시장은 2025년에는 115억 4,000만 달러로 추정되고, 2032년에는 425억 7,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 연평균 성장률(CAGR)은 20.5%를 나타낼 전망입니다.
| 보고 범위 |
보고서 세부정보 |
| 기준 연도 |
2024년 |
시장 규모(2025년) |
115억 4,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간 : 2025-2032년 CAGR : |
20.50% |
가치 예측(2032년) |
425억 7,000만 달러 |
디지털 치료제(DTx)는 의료 질환이나 질병을 예방, 관리, 치료하기 위한 소프트웨어에 의한 근거에 근거한 치료 개입입니다.
시장 역학 :
만성 질환 부담 증가, COVID-19(팬데믹) 발생, 환자 중심 건강 관리 앱 채택 증가, 디지털 건강 관리 솔루션 및 기술 채용 증가, 정부의 예방 의료에 대한 주력 증가는 세계의 디지털 치료제(DTx) 시장 성장을 증가시킬 것으로 예상되는 주요 요인입니다.
예를 들어, 2022년 2월, DynamiCare Health Inc.는 미국 식품의약국(FDA)으로부터 임신·출산에 합병하는 담배 사용 장애를 치료하는 처방전만의 디지털 치료제(DTx) DCH-001의 브레이크스루 디바이스 지정을 받았다고 발표했습니다.
아메리소스 바겐은 2022년 7월 혁신적인 제품에 대한 액세스를 용이하게 하기 위해 디지털 세라퓰틱스(DTx) 플랫폼의 출시했습니다.
본 조사의 주요 특징
- 본 보고서는 세계의 디지털 치료제(DTx) 시장을 상세하게 분석하여 2024년을 기준연도로 하여 2025년부터 2032년의 예측기간에 있어서 시장 규모 및 복합연간 성장률(CAGR%)을 제공합니다.
- 또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 발매 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 인사이트도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 아래의 파라미터를 바탕으로 세계의 디지털 치료제(DTx) 시장 주요 기업을 프로파일하고 있습니다.
- 본 보고서로부터의 인사이트에 의해 마케팅 담당자나 기업의 경영진은 향후 제품 발매, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
- 세계의 디지털 치료제(DTx) 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해 관계자에 대응하고 있습니다.
- 이해관계자는 세계의 디지털 치료제(DTx) 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- 일관된 기회 맵(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 세계에서 만성질환의 부담이 증가
- 환자 데이터의 프라이버시에 관한 우려
- 디지털 치료제(DTx)의 채용 확대
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- PORTER 분석
- 합병과 인수 시나리오
제4장 세계의 디지털 치료제(DTx) 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측의 분석
- 경제에 미치는 영향
제5장 세계의 디지털 치료제(DTx) 시장, 용도별(2020-2032년)
- 당뇨병
- 비만
- 심혈관질환(CVD)
- 중추신경계(CNS) 질환
- 호흡기 질환
- 금연
- 위장장애(GID)
- 기타
제6장 세계의 디지털 치료제(DTx) 시장, 제품 유형별(2020-2032년)
제7장 세계의 디지털 치료제(DTx) 시장, 판매 채널별(2020-2032년)
- 기업 간 거래(B2B)
- 고용주
- 의료 제공자
- 기타
- 기업 대 소비자(B2C)
- 환자
- 간병인
제8장 세계의 디지털 치료제(DTx) 시장, 지역별(2020-2032년)
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제9장 경쟁 구도
- Happify, Inc.
- 2Morrow, Inc.
- Akili Interactive Labs, Inc.
- Click Therapeutics, Inc.
- Fitbit, Inc.(Twine Health, Inc.)
제10장 섹션
KTH
영문 목차
Digital Therapeutics Market is estimated to be valued at USD 11.54 Bn in 2025 and is expected to reach USD 42.57 Bn by 2032, growing at a compound annual growth rate (CAGR) of 20.5% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 11.54 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
20.50% |
2032 Value Projection: |
USD 42.57 Bn |
Digital Therapeutics (DTx) are evidence-based therapeutic interventions driven by the software to prevent, manage, or treat a medical disorder or disease. Digital Therapeutics are a part of the digital healthcare that deliver therapeutic interventions directly to patients via evidence-based, clinically-evaluated software for disease management.
Market Dynamics:
Increasing burden of chronic diseases, the outbreak of COVID-19 (pandemic), increasing adoption of patient-centric healthcare apps, growing adoption of digital healthcare solutions or technologies, and increasing focus toward preventive healthcare by governments are major factors expected to augment the growth of the global digital therapeutics market.
For instance, in February 2022, DynamiCare Health Inc. announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for the DCH-001, a prescription-only digital therapeutic to treat tobacco use disorder complicating pregnancy and childbirth.
Moreover, in July 2022, AmerisourceBergen planned to launch digital therapeutics (DTx) platform to facilitate access to innovative products. The platform enables doctors to easily access and order prescription and non-prescription DTx through their e-prescribing workflow and monitor patient fulfilment of digital therapeutics and diagnostics.
Key features of the study:
- This report provides in-depth analysis of the global digital therapeutics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global digital therapeutics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Happify, Inc., 2Morrow, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., and Fitbit, Inc. (Twine Health, Inc.).
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global digital therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital therapeutics market.
Detailed Segmentation:
- Global Digital Therapeutics Market, By Application:
- Diabetes
- Obesity
- Cardiovascular Disease (CVD)
- Central Nervous System (CNS) Disease
- Respiratory Disease
- Smoking Cessation
- Gastrointestinal Disorder (GID)
- Others
- Global Digital Therapeutics Market, By Product Type:
- Global Digital Therapeutics Market, By Sales Channel:
- Business-to-Business (B2B)
- Employer
- Healthcare Provider
- Others
- Business-to-Consumer (B2C)
- Patient
- Caregiver
- Global Digital Therapeutics Market, By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles:
- Happify, Inc.
- 2Morrow, Inc.
- Akili Interactive Labs, Inc.
- Click Therapeutics, Inc.
- Fitbit, Inc. (Twine Health, Inc.)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By Product Type
- Market Snapshot, By Sales Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rise in burden of chronic diseases around the world
- Concerns about patient data privacy
- Increasing adoption of digital therapeutics (DTx)
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Digital Therapeutics Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Digital Therapeutics Market, By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Obesity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Cardiovascular Disease (CVD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Central Nervous System (CNS) Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Smoking Cessation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Gastrointestinal Disorder (GID)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Global Digital Therapeutics Market, By Product Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Device
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Digital Therapeutics Market, By Sales Channel, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Business-to-Business (B2B)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Employer
- Healthcare Provider
- Others
- Business-to-Consumer (B2C)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Patient
- Caregiver
8. Global Digital Therapeutics Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
9. Competitive Landscape
- Happify, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 2Morrow, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Akili Interactive Labs, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Click Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fitbit, Inc. (Twine Health, Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
관련자료
